- Home
- CLW vs MIST Comparison
CLW vs MIST Comparison
Compare CLW & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLW | MIST |
|---|---|---|
| Founded | 1926 | 2003 |
| Country | United States | Canada |
| Employees | 3710 | N/A |
| Industry | Paper | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.3M | 176.3M |
| IPO Year | 2008 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CLW | MIST |
|---|---|---|
| Price | $14.86 | $1.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $23.00 | $8.50 |
| AVG Volume (30 Days) | 188.6K | ★ 2.1M |
| Earning Date | 04-28-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,555,400,000.00 | N/A |
| Revenue This Year | N/A | $1,653.36 |
| Revenue Next Year | $4.16 | $12.32 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.42 | N/A |
| 52 Week Low | $12.46 | $0.63 |
| 52 Week High | $30.96 | $3.06 |
Technical Indicators
Market Signals| Indicator | CLW | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 55.16 | 46.10 |
| Support Level | $12.46 | N/A |
| Resistance Level | $18.85 | $2.01 |
| Average True Range (ATR) | 0.67 | 0.13 |
| MACD | 0.28 | -0.01 |
| Stochastic Oscillator | 91.95 | 48.10 |
Price Performance
Historical ComparisonAbout CLW Clearwater Paper Corporation
Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).